Pal Suman, Shekhar Rahul, Kottewar Saket, Upadhyay Shubhra, Singh Mriganka, Pathak Dola, Kapuria Devika, Barrett Eileen, Sheikh Abu Baker
Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87106, USA.
Department of Internal Medicine, Division of Hospital Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Vaccines (Basel). 2021 Nov 19;9(11):1358. doi: 10.3390/vaccines9111358.
Vaccine reluctance among healthcare workers (HCW) can have widespread negative ramifications, including modeling behavior for the general population and challenges with maintaining a healthy workforce so we can respond to a resurgence of the pandemic. We previously reported that only one-third of HCW were willing to take the vaccine as soon as it became available prior to its Emergency Use Authorization (EUA). Here, we re-examine the attitude toward COVID-19 vaccines among HCW several months after the vaccines have been made widely available. In this study, only 7.9% (n = 107) of respondents were hesitant to take the first or second dose of the vaccine. Younger age (18-40 years) and lower level of education attainment (GED or less) were associated with higher vaccine hesitancy, whereas self-identified Asian racial identity was associated with greater acceptance of COVID-19 vaccination. Among the vaccine-hesitant group, more respondents noted mistrust of regulatory authorities (45.3%), government (48.6%), and pharmaceutical companies (50%) than mistrust of doctors (25.4%). Nearly two-thirds of respondents were concerned that vaccination may be ineffective against new strains and booster doses may be required; however, vaccine-hesitant respondents' acceptance of a hypothetical booster dose was only 14.3%. Overall, vaccine hesitancy was observed to have demographic predictors similar to those previously reported; the hesitancy of some US HCW to receive booster doses may reflect a general hesitancy to receive other forms of vaccination.
医护人员对疫苗的抵触情绪可能会产生广泛的负面影响,包括为普通民众树立行为榜样,以及在维持健康劳动力队伍方面面临挑战,从而影响我们应对疫情的卷土重来。我们之前报告称,在紧急使用授权(EUA)之前,只有三分之一的医护人员愿意在疫苗一有供应时就接种。在此,我们重新审视了在疫苗广泛供应数月后医护人员对新冠疫苗的态度。在这项研究中,只有7.9%(n = 107)的受访者对接种第一剂或第二剂疫苗犹豫不决。年龄较轻(18 - 40岁)和教育程度较低(普通教育发展证书或更低)与更高的疫苗犹豫程度相关,而自我认同为亚裔种族身份与对新冠疫苗接种的更高接受度相关。在疫苗犹豫群体中,更多受访者表示不信任监管机构(45.3%)、政府(48.6%)和制药公司(50%),而不是不信任医生(25.4%)。近三分之二的受访者担心接种疫苗可能对新毒株无效,可能需要接种加强针;然而,对疫苗持犹豫态度的受访者对假设的加强针的接受度仅为14.3%。总体而言,观察到疫苗犹豫与之前报告的人口统计学预测因素相似;一些美国医护人员对接种加强针的犹豫可能反映出他们对接受其他形式疫苗接种普遍存在犹豫。